| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $9.1M | +38.0% | +49.1% |
| SG&A Expense | $5.8M | +41.9% | +6.0% |
| Operating Income | -$14.9M | -39.5% | -26.9% |
| Net Income | -$12.9M | -48.7% | -44.9% |
| EPS (Basic) | -$0.19 | -46.2% | -46.2% |
| EPS (Diluted) | -$0.19 | -46.2% | -46.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.8M | +13.8% | -82.3% |
| Short-term Investments | $61.1M | -1.5% | +29.5% |
| Current Assets | $91.0M | +4.1% | -54.0% |
| Total Assets | $182.3M | -5.2% | -18.0% |
| Current Liabilities | $4.9M | -20.2% | +44.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$38.7M | — | — |
| Capital Expenditures | $186K | — | — |
| Investing Cash Flow | -$22.7M | — | — |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | -$38.9M | — | — |
| $5.3M |
| -19.9% |
| +54.9% |
| Stockholders' Equity | $177.0M | -4.7% | -19.1% |